Canine Osteosarcoma: Welfare and Palliative Care

Key Welfare Considerations

• Osteosarcoma most commonly affects large and giant breeds — Great Danes, Irish Wolfhounds, Greyhounds.
• The appendicular skeleton (limbs) is affected in 75% of cases — weight-bearing bone destruction causes severe welfare pain.
• Bone pain from osteosarcoma is often described as among the most severe welfare pain in veterinary medicine.
• Pathological fracture through tumour-weakened bone is a welfare emergency requiring immediate management.
• Amputation provides the most effective pain welfare relief and potentially extends survival with chemotherapy.
• Median survival with amputation alone is 4-6 months; adjuvant carboplatin extends to 10-12 months.
• Limb-sparing surgery is an option for selected cases when donor bone is available.
• Dogs adapt remarkably well to amputation — welfare quality of life is typically excellent post-recovery.
• Palliative radiotherapy provides welfare pain relief without tumour removal in non-surgical cases.
• Bisphosphonate therapy (pamidronate, zoledronate) reduces bone resorption pain welfare burden.
• Multimodal analgesia is essential — NSAIDs, gabapentin, and opioids provide layered welfare pain control.
• Forced rest and activity restriction protect against pathological fracture welfare emergency.
• Quality of life assessment using validated welfare scales guides treatment decisions and euthanasia timing.
• Palliative care conversations should begin at diagnosis — welfare-focused decision-making supports owners.
• Early, compassionate euthanasia when welfare deteriorates is a morally sound decision in osteosarcoma management.